Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Fuchs Henry J
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   222,228    

Indirect Shares

  0      
Direct Value   $18,063,061    

Indirect Value

  $0      
Total Shares   222,228      
Total Value   $18,063,061      


Onyx Pharmaceuticals Inc
 $0 Biomarin Pharmaceutical Inc
 $17,448,765 Mirati Therapeutics, Inc.
 $614,296 Onyx Pharmaceuticals Inc
 $0 Biomarin Pharmaceutical Inc
 $17,448,765 Mirati Therapeutics, Inc.
 $614,296
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Medical Of... 2008-11-18 14,891 2006-05-15 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2012-06-19 0 2007-12-05 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN President, Worldwide R&D 2024-03-15 196,872 2009-03-02 0    Premium*  
            Genomic Health Inc GHDX Director 2019-11-08 0 2014-04-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2023-01-20 10,465 2020-01-03 0    Premium*  
* Premium Members only  

Records found :    294         Free Registration Required For Full Results.    Limit: 25

Download
  Page 9 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2008-06-23 4 AS $35.30 $220,625 D/D (6,250) 16,975 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2013-04-30 4 OE $11.05 $221,000 D/D 20,000 64,589 0 -
RDEA Ardea Biosciences Inc Director   –       •      –    2007-12-04 4 OE $2.76 $221,374 D/D 80,208 83,107 0 -
MRTX Mirati Therapeutics, Inc.   –       •      –    2022-02-11 4 OE $20.54 $225,940 D/D 11,000 17,021 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-06-05 4 AS $122.32 $228,001 D/D (1,864) 72,846 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-05-18 4 AS $124.78 $232,584 D/D (1,864) 76,746 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2008-09-15 4 AS $37.32 $233,250 D/D (6,250) 15,933 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-06-04 4 D $120.46 $245,257 D/D (2,036) 74,710 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-05-15 4 D $122.78 $249,980 D/D (2,036) 78,610 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-05-06 4 D $80.80 $252,985 D/D (3,131) 117,950 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-04-20 4 AS $35.00 $269,185 D/D (7,691) 28,920 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-03-03 4 D $89.57 $272,562 D/D (3,043) 100,876 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-03-03 4 D $93.95 $274,710 D/D (2,924) 125,518 0 -
GHDX Genomic Health Inc Director   –       •      –    2019-02-25 4 S $78.88 $278,226 D/D (3,521) 6,332 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2007-08-13 4 OE $21.01 $315,150 D/D 15,000 33,334 0 -
RDEA Ardea Biosciences Inc Director   –       •      –    2012-04-25 4 AS $31.64 $316,432 D/D (10,000) 10,416 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2007-08-10 4 S $32.00 $320,011 D/D (10,000) 18,334 0 -
RDEA Ardea Biosciences Inc Director   –       •      –    2012-06-19 4 D $32.00 $333,312 D/D (10,416) 0 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-04-02 4 OE $26.49 $337,851 D/D 10,000 163,326 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-05-11 4 AS $121.64 $348,988 D/D (2,869) 83,646 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-04-20 4 S $27.00 $355,455 D/D (13,165) 22,835 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-05-08 4 D $121.66 $380,917 D/D (3,131) 86,515 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-05-26 4 OE $26.49 $397,350 D/D 15,000 130,914 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-08-26 4 OE $26.49 $397,350 D/D 15,000 128,878 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2016-11-25 4 OE $26.49 $397,350 D/D 15,000 128,878 0 -

  294  Records found
  1   2   3   4   5   6   7   8   9  10   11   12      
  Page 9 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed